B00.51 Herpesviral iridocyclitis

Name of the Condition

• Herpesviral iridocyclitis

Summary

Herpesviral iridocyclitis is an inflammatory condition of the eye caused by the herpes simplex virus (HSV), specifically affecting the iris and ciliary body. This condition is a subset of herpesviral ocular disease and may present with acute or chronic symptoms, potentially leading to vision impairment if not properly managed. The inflammation can be localized or part of a broader ocular infection, requiring careful clinical evaluation to determine the extent of involvement.

Causes

The condition is caused by the herpes simplex virus (HSV), a member of the Herpesviridae family. Transmission occurs through direct contact with infected ocular secretions or asymptomatic viral shedding. HSV-1 is the primary subtype associated with ocular infections, though HSV-2 can also be involved in some cases. Reactivation of latent virus in individuals with prior exposure is a common mechanism leading to recurrent iridocyclitis.

Risk Factors

• Close contact with an individual who has an active HSV infection or asymptomatic shedding.
• Immunocompromised states, such as HIV/AIDS, chemotherapy, or chronic steroid use.
• Pre-existing ocular conditions, including trauma or inflammation.
• Age, with neonates and older adults at increased risk for severe disease.

Symptoms

• Eye pain, redness, or irritation.
• Blurred vision or sensitivity to light.
• Pupil abnormalities, such as irregular shape or poor response to light.
• Possible presence of corneal involvement, such as dendritic ulcers.
• In severe cases, increased intraocular pressure or vision loss.

Diagnosis

Diagnosis is based on clinical evaluation, including a detailed eye examination and history of HSV infection or exposure. Slit-lamp biomicroscopy may reveal characteristic findings, such as keratic precipitates or anterior chamber inflammation. Laboratory tests, such as viral cultures or PCR, can confirm HSV involvement, though clinical correlation is essential. Differentiation from other causes of uveitis is critical to guide appropriate management.

Treatment Options

Treatment typically involves antiviral medications, such as acyclovir or valacyclovir, to target the underlying HSV infection. Topical or systemic corticosteroids may be used to reduce inflammation, often in combination with antivirals to prevent viral replication. Dilating drops can help relieve pain and prevent complications like synechiae. Management of intraocular pressure may be necessary in some cases.

Prognosis and Follow-Up

Prognosis depends on the severity of inflammation and timely treatment. Early intervention often leads to favorable outcomes, but recurrent episodes or delayed care can result in vision loss. Regular follow-up is essential to monitor for complications, adjust therapy, and assess visual function. Patients with recurrent disease may require long-term antiviral prophylaxis.

Complications

• Chronic inflammation leading to cataracts or glaucoma.
• Corneal scarring or endothelial dysfunction.
• Vision loss due to untreated or severe disease.
• Recurrent episodes requiring ongoing management.

Lifestyle & Prevention

• Avoid touching the eyes with unwashed hands to reduce infection risk.
• Manage underlying conditions that may compromise immunity.
• Use protective eyewear to prevent ocular trauma.
• Follow prescribed antiviral regimens to prevent recurrence.

When to Seek Professional Help

Seek immediate medical attention if experiencing sudden eye pain, vision changes, or severe redness, as these may indicate acute inflammation or complications. Regular follow-up is recommended for those with a history of HSV ocular disease to monitor for recurrence or progression.

Tips for Medical Coders

When coding for herpesviral iridocyclitis, use the ICD-10-CM code B00.51. Ensure documentation supports the diagnosis, including clinical findings, diagnostic tests, and treatment. Differentiate from other ocular infections or inflammatory conditions to avoid miscoding. Note the specific involvement of the iris and ciliary body, as this distinguishes the condition from broader herpesviral ocular disease codes.